Jim Cramer on Eli Lilly and Company (LLY)’s Q4 2024 Performance: ‘Aren’t As Strong As Wall Street Was Hoping’
We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli ...
Eli Lilly Missed Sales Expectations Again. Should Investors Be Worried?
Sales of Eli Lilly's lead drug, tirzepatide, which it markets as Zepbound for weight loss and Mounjaro for diabetes, leapt up to a combined $5.4 billion in the fourth quarter. That's some amazing ...
The New York Times19h
World News
By James Wagner and Luis Antonio Rojas CreditLuis Antonio Rojas for The New York Times. From the Surf to the Sermon: The Christian Surfers of Costa Rica A group of missionaries who surf have ...
The New York Times19h
About New York Times Games
Since the launch of The Crossword in 1942, The Times has captivated solvers by providing engaging word and logic games. In 2014, we introduced The Mini Crossword — followed by Spelling Bee ...